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Culligan, Kevin, Niamh Banville, Paul Dowling, and
Kay Ohlendieck. Drastic reduction of calsequestrin-like
proteins and impaired calcium binding in dystrophic mdx
muscle. J Appl Physiol 92: 435–445, 2002; 10.1152/jappl-
physiol.00903.2001.—Although the reduction in dystrophin-
associated glycoproteins is the primary pathophysiological
consequence of the deficiency in dystrophin, little is known
about the secondary abnormalities leading to x-linked mus-
cular dystrophy. As abnormal Ca2 handling may be in-
volved in myonecrosis, we investigated the fate of key Ca2
regulatory membrane proteins in dystrophic mdx skeletal
muscle membranes. Whereas the expression of the ryanodine
receptor, the dihydropyridine receptor, the Ca2-ATPase,
and calsequestrin was not affected, a drastic decline in calse-
questrin-like proteins of 150–220 kDa was observed in dys-
trophic microsomes using one-dimensional immunoblotting,
two-dimensional immunoblotting with isoelectric focusing,
diagonal two-dimensional blotting technique, and immuno-
precipitation. In analogy, overall Ca2 binding was reduced
in the sarcoplasmic reticulum of dystrophic muscle. The
reduction in Ca2 binding proteins might be directly involved
in triggering impaired Ca2 sequestration within the lumen
of the sarcoplasmic reticulum. Thus disturbed sarcolemmal
Ca2 fluxes seem to influence overall Ca2 homeostasis,
resulting in distinct changes in the expression profile of a
subset of Ca2 handling proteins, which might be an impor-
tant factor in the progressive functional decline of dystrophic
muscle fibers.
calcium binding proteins; calcium homeostasis; calcium se-
questration; muscular dystrophy; sarcoplasmic reticulum
THE DYSREGULATION OF Ca2 handling has been recog-
nized as playing a central role in rare neuromuscular
disorders, such as malignant hyperthermia, central
core disease, and Brody’s disease (24, 35, 44). Abnor-
mal Ca2 homeostasis has also been described in more
frequent disorders of skeletal and heart muscle cells,
i.e., alcoholic myopathy (63) and dilated cardiomyopa-
thy (41). In the case of the most commonly inherited
neuromuscular disorder, Duchenne muscular dystro-
phy (17), there is still debate about whether cytosolic
accumulation of calcium ions and the accompanied
Ca2-induced proteolysis (70) and/or altered develop-
mental programming of regenerating myofibers (10)
represents one of the major pathophysiological path-
ways leading to skeletal muscle fiber destruction (11).
Conflicting reports have been published on the extent
of perturbation of overall Ca2 homeostasis in dystro-
phin-deficient muscle cells (28). Although Steinhardt
and co-workers (2, 3, 19, 33, 68, 69) have postulated
that ion flux through Ca2 leak channels is responsible
for an elevated Ca2-dependent net degradation of
muscle proteins in dystrophic muscle cells, results
from several other research groups do not agree with
the idea of a drastic increase in total Ca2 levels (12,
26, 32, 37, 64). An explanation for the contradictory
findings could be that the cytosolic Ca2 overload is not
global but restricted to subsarcolemmal domains in
dystrophic muscle fibers (48, 49). In addition, abnormal
Ca2 homeostasis in mitochondria might also be in-
volved in the muscular degeneration process (65). In-
dependent of the total extent and exact microdomain
localization of the initial Ca2 disturbance, even small
changes in Ca2 cycling might trigger a cascade of
modifications in ion-regulatory membrane complexes.
To determine whether protein degradation and/or com-
pensatory up- or downregulation of individual ele-
ments of the Ca2 handling apparatus occurs in dys-
trophin-deficient muscle cells, we have analyzed key
components involved in the regulation of excitation-
contraction coupling.
The motoneuron-induced sarcolemmal depolariza-
tion is sensed by transverse-tubular sensors and is
physiologically coupled to the activation of the contrac-
tile apparatus via the Ca2 release system of the sar-
coplasmic reticulum (SR) (50, 54). Two well-character-
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ized Ca2-channel complexes represent the central
elements of this excitation-contraction coupling pro-
cess: the voltage-sensing dihydropyridine receptor (8)
and the ryanodine receptor (RyR) Ca2 release channel
(20). In skeletal muscle, both receptors directly inter-
act during signal transduction at the triad junction
(42), whereas, in developing skeletal muscle and car-
diac fibers, a Ca2-induced Ca2 release mechanism
appears to be the dominant process (7). The skeletal
muscle dihydropyridine receptor consists of the princi-
pal 1S-subunit, which contains the voltage-sensing
domain and the pore-forming structures, as well as the
auxiliary subunits 2, -, and -, which have impor-
tant regulatory functions (30). The Ca2 release chan-
nel complex of the junctional SR is formed by the
tetrameric RyR structure (66). Triadin and several not
yet biochemically characterized junctional proteins are
auxiliary components (22, 25, 72). After contraction,
the Ca2-ATPase of the longitudinal tubules and ter-
minal cisternae provides a rapid re-uptake mechanism
for the removal of calcium ions during muscle relax-
ation (46, 66). Ca2 sequestration within the SR lumen
is mediated by various Ca2 binding proteins, such as
calsequestrin, sarcalumenin, and calreticulin (40, 52,
57). As a high-capacity ion-binding protein, calseques-
trin has a central position in Ca2 homeostasis (45). It
has been shown to be an important endogenous regu-
lator of the Ca2 release channel (58). In contrast to
calsequestrin of 63 kDa, the exact function of several
calsequestrin-like proteins (CLPs) of higher molecular
mass is not well understood (5, 47).
Although earlier studies (18, 39, 53, 62, 71) have
analyzed the dystrophic chicken and merosin-deficient
dy mouse, no comprehensive study has addressed the
status of key Ca2 regulatory membrane proteins in an
established animal model of x-linked Duchenne mus-
cular dystrophy such as the mdx mouse. Leg and torso
mdx skeletal muscle fibers do not exhibit all of the
observed pathobiochemical changes as seen in muscle
specimens from patients afflicted with Duchenne mus-
cular dystrophy (17). However, they do exhibit segmen-
tal necrosis (67), stretch-induced injury (43), increased
susceptibility to osmotic shock (51), alterations of ex-
citation-contraction coupling (15), and a drastic de-
crease in dystrophin-associated glycoproteins (13, 59),
making them a suitable disease model (4). It was,
therefore, of interest to determine potential secondary
changes in Ca2 regulatory proteins in mdx muscle
preparations.
MATERIALS AND METHODS
Dystrophic animal model. Eight-wk-old normal control
and dystrophic mdx mice (Jackson Laboratory, Bar Harbor,
MN) were comparatively analyzed in this study. The mdx
mouse lacks the dystrophin isoform Dp427 due to a point
mutation in exon 23, making it a suitable animal model for
studying potential pathophysiological changes in x-linked
muscular dystrophy (4). Although not a perfect replica of the
human disease process, this mouse model exhibits many of
the muscular degeneration processes seen in Duchennne
muscular dystrophy (6, 59). To establish the mutant status of
the mdx mice used in this study, microsomal membranes and
muscle cryosections were analyzed for the dystrophin isoform
Dp427 by immunoblotting (see Fig. 1A) and immunofluores-
cence microscopy (see Fig. 6D), respectively.
Reagents. Protease inhibitors and acrylamide stock solu-
tions were purchased from Boehringer Mannheim (Lewis,
East Sussex, UK). Western blotting chemiluminescence sub-
strates and Slide-A-Lyzer Mini Dialysis MWCO-10000 cas-
Fig. 1. Immunoblot analysis of Ca2 regulatory mem-
brane proteins in dystrophic mdx skeletal muscle.
Shown are immunoblots decorated with antibodies to
the Dp427 isoform of dystrophin (A), -dystroglycan
(DG; -DG; B), -DG (C), -sarcoglycan (-SG; D), lami-
nin (LAM; E), the -subunit of the Na-K-ATPase
(NKA; F), the 1S-subunit of the voltage-sensing dihy-
dropyridine receptor (DHPR; 1S-DHPR; G), the 2-
subunit of the transverse-tubular DHPR (2-DHPR; H),
the -subunit of the DHPR (-DHPR; I), the ryanodine
receptor (RyR)1 isoform of the RyR Ca2 release chan-
nel of the sarcoplasmic reticulum (J), the fast-twitch
isoform of the sarco(endo)plasmic reticulum Ca2-AT-
Pase (SERCA)1 (K), and calsequestrin (CSQ) of appar-
ent 63 kDa and the 3 CSQ-like proteins (CLP) of 150
kDa (CLP-150), 170 kDa (CLP-170), and 220 kDa (CLP-
220) (L). Lanes 1 and 2 represent microsomal mem-
branes isolated from normal control and dystrophic
mdx skeletal muscle, respectively. The position of im-
munodecorated protein bands is marked by arrow
heads.
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settes were obtained from Pierce & Warriner (Chester,
Cheshire, UK). Ecoscint-A scintillation fluid was from Na-
tional Diagnostics (Hull, UK). Immobilon-P nitrocellulose
sheets were from Millipore (Bedford, MA). Reagents for iso-
electric focusing (impedance pneumograph pH 3–10 strips
and impedance pneumograph pH 3–10 buffer systems), as
well as 45CaCl2, were obtained from Amersham Pharmacia
Biotech AB (Uppsala, Sweden). Superfrost Plus positively
charged microscope slides were from Menzel Gla¨sser (Braun-
schweig, Germany), and Kodacolor Gold 400ASA VR film was
obtained from Eastman Kodak (Rochester, NY). All other
chemicals, including those for membrane isolation, electro-
phoresis, and blotting, were of analytic grade and purchased
from Sigma Chemical (Poole, Dorset, UK).
Antibodies. Characterization of established antibodies to
the dystrophin-glycoprotein complex and ion-regulatory mus-
cle proteins was performed as previously described (13, 21).
Monoclonal antibody (MAb) IIID5 against the 1-subunit of
the dihydropyridine receptor and MAb VD21 to the -subunit
of the dihydropyridine receptor were a generous gift from Dr.
Kevin P. Campbell (University of Iowa, Iowa City, IA). A
polyclonal antibody to -sarcoglycan was raised by four
monthly injections of a peptide representing the last 15
residues of the carboxy-terminus using a standard immuni-
zation protocol (13). Peptides had been synthesized and cou-
pled to keyhole limpet hemocyanin carrier by Research Ge-
netics (Huntington, AL). Antisera to junctin were a generous
gift of Dr. Steve Cala (Wayne State University, Detroit, MI)
(29). Commercially available primary antibodies were from
Novocastra Laboratories (Newcastle upon Tyne, UK; MAb
NCL-43 against -dystroglycan, MAb DYS-1 to the Dp427
rod domain), Upstate Biotechnology (Lake Placid, NY; MAb
VIA41 to -dystroglycan, MAb c464.6 to the -subunit of the
Na-K-ATPase), Affinity Bioreagents [Golden, CO; MAb
VIIID12 to calsequestrin, MAb 20A to the 2-subunit of the
dihydropyridine receptor, MAb IIH11 to the fast-twitch sar-
co(endo)plasmic reticulum Ca2-ATPase (SERCA)1 isoform
of the SR Ca2-ATPase], and Sigma Chemical (MAb 34C to
the RyR1 isoform of the RyR Ca2 release channel). Peroxi-
dase- or fluorescein-conjugated secondary antibodies were
purchased from Boehringer Mannheim.
Isolation of microsomal membranes. For gel electro-
phoretic and immunoblot analysis, as well as 45CaCl2 bind-
ing and Ca2-ATPase assays, microsomal membranes were
isolated from normal control and mdx leg and back skeletal
muscle homogenates by an established subcellular fraction-
ation procedure (55). To minimize proteolytic degradation, all
procedures were carried out at 4°C, and all buffers contained
a protease inhibitor cocktail [0.3 M trans-epoxysuccinyl-L-
leucylamido(4-guanidino)butane (E-64), 0.2 mM pefabloc, 1.4
M pepstatin, 0.15 M aprotinin, 1 M leupeptin, 0.5 M
soybean trypsin inhibitor, and 1 mM EDTA]. Final micro-
somal membrane pellets were resuspended at a protein con-
centration of 10 mg/ml and used immediately for gel electro-
phoretic separation, Ca2 binding studies, and Ca2-ATPase
assays.
Gel electrophoresis and immunoblotting. Gel electro-
phoretic separation using one-dimensional 5% (wt/vol) or 7%
(wt/vol) resolving gels with a 5% (wt/vol) stacking gel in the
presence of SDS and dithiothreitol was performed for 200
V h employing a Mini-MP3 electrophoresis system from Bio-
Rad Laboratories (Hempel Hempstead, Herts, UK), whereby
25 g protein was loaded per well (23). The two-dimensional
gel electrophoresis techniques used in this study have been
previously optimized for the analysis of integral muscle
membrane proteins in our laboratory. This includes diagonal
nonreducing/reducing two-dimensional gel electrophoresis
for the determination of complex formation (47) and standard
two-dimensional gels using isoelectric focusing in the first
dimension and SDS polycarylamide gel electrophoresis in the
second dimension for the evaluation of isoelectric point (pI)
values of individual protein isoforms (23). Immunodecoration
of nitrocellulose replicas of polyacrylamide gels (21) was
carried out by established procedures using the enhanced
chemiluminescence technique (31). Densitometric scanning
of enhanced chemiluminescence blots was performed on a
Molecular Dynamics 300S computing densitometer (Sunny-
vale, CA) with ImageQuant V3.0 software.
Immunoprecipitation. Comparative immunoprecipitation
experiments were performed as previously described (29).
Microsomal membranes from both normal control and dys-
trophic mdx muscle were solubilized in a 1% (vol/vol) Tween-
20-containing buffer (50 mM Tris Cl; pH 7.5, 150 mM NaCl,
1 mM EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 0.3 M
E-64, 0.2 M pefabloc), and precleared with a 1:1 slurry of
protein A-Sepharose (Sigma Chemical) for 1 h at 4°C to allow
removal of nonspecific binding proteins. Formation of the
antigen-antibody complexes was then achieved by incubation
of the supernatant with a 1:20 dilution of MAb VIIID12 to
calsequestrin for 2 h at 4°C. Antigen-antibody complexes
were removed by addition of an equal volume of a 1:1 slurry
of protein A-Sepharose. The suspension was slowly rotated
for 1 h at 4°C. After sedimentation and three washes with the
above buffer, the antigen-antibody complexes were removed
from the Sepharose beads by boiling in reducing electro-
phoresis buffer for 5 min. The eluted complexes were sepa-
rated by standard SDS polyacrylamide gel electrophoresis
and analyzed by immunoblot analysis.
Calcium-binding and calcium-ATPase assay. Compara-
tive binding experiments using radiolabeled 45CaCl2 and
assays of Ca2-ATPase enzyme activity were performed by
standard methods (60). For equilibrium dialysis, micro-
somal vesicles derived from normal control or dystrophic
mdx muscle (0.1 mg protein) were placed in a Slide-A-
Lyzer Mini Dialysis MWCO-10000 cassette system
(0.25-ml volume) and dialyzed against 100 ml of 5 mM
Tris  Cl, pH 7.5, 0.1 mM 45CaCl2 (20,000 counts  min1 
ml1) for 24 h at 4°C. Equal samples from both inside and
outside the dialysis cassette were dissolved in 10 ml of
Ecoscint-A scintillation fluid and were radioactivity
counted in a standard scintillation counter. Specific Ca2
binding per milligram protein could then be calculated
from the increased radioactivity within the dialysis cas-
sette. To determine potential differences in the Ca2-
ATPase enzyme activity between normal and dystrophic
microsomes, the direct colorimetric assay procedure using
a malachite green-molybdate-polyvinyl alcohol mixed re-
agent (9) was employed (60). Ca2-ATPase activity was
calculated by comparison of measurements with a potas-
sium dihydrogen phosphate standard graph.
Immunofluorescence microscopy. For indirect immunofluo-
rescence microscopy, the tibialis anterior muscle from nor-
mal control and dystrophic mdx mice was quick-frozen in
liquid nitrogen-cooled isopentane and stored at 70°C before
cryosectioning. Transverse sections of 12 m thickness were
prepared using a standard cryostat (Microm, Heidelberg,
Germany), mounted on Superfrost Plus positively charged
microscope slides and subsequently fixed, blocked, washed,
hematoxylin-and-eosin stained, or immunolabeled with pri-
mary and secondary antibodies, and then photographed for
documentation, as previously described (13).
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RESULTS
Although the primary genetic defects leading to the
various forms of muscular dystrophy have been iden-
tified, very little is known about the secondary abnor-
malities leading to myonecrosis. Studies over recent
years have produced conflicting data with respect to
changes in cytosolic Ca2 levels, the postulated trig-
gering factor in Ca2-induced muscle cell destruction.
To determine novel potential factors involved in the
pathophysiology of dystrophin-deficient muscle fibers,
we have investigated the fate of key Ca2 regulatory
membrane proteins involved in the regulation of exci-
tation-contraction coupling. A survey of triad and SR
markers was carried out using one-dimensional immu-
noblotting with established antibodies (Fig. 1), fol-
lowed by a more in-depth analysis of CLPs (Fig. 2), two
different two-dimensional immunoblot techniques with
isolectric focusing or diagonal gel separation (Fig. 3),
immunoprecipitation (Fig. 4), Ca2 binding and Ca2-
ATPase assays of SR vesicles employing equilibrium
dialysis and enzyme testing, respectively (Fig. 5), and
comparative histological and immunofluorescence
microscopy of normal and dystrophic muscle fibers
(Fig. 6).
Characterization of mdx microsomes. Before analysis
of the three main excitation-contraction coupling ele-
ments, i.e., the transverse-tubular voltage sensor, the
Ca2 release channel complex of the junctional SR, and
the luminal Ca2 reservoir complex, the dystrophic
status of the mdx preparation was established. As
illustrated in Fig. 1, A–D, microsomal membranes iso-
lated from mdx skeletal muscle homogenates were
completely deficient in the Dp427 isoform of dystrophin
and exhibited a greatly reduced expression of the
dystrophin-associated glycoproteins: -dystroglycan,
-dystroglycan, and -sarcoglycan. In analogy to dys-
trophic muscle from patients afflicted with Duchenne
muscular dystrophy, this reduction in dystrophin-asso-
ciated surface proteins is believed to play a central role
in the pathomolecular process leading to myonecrosis
(6, 59), making mdx microsomes a suitable model sys-
tem for studying potential dystrophy-induced changes
in Ca2 handling proteins. In contrast to the dystro-
glycans and -sarcoglycan, laminin, the extracellular
protein linked to the dystrophin-glycoprotein complex
via -dystroglycan, was shown not to be reduced in
dystrophic microsomes but exhibited a slightly in-
creased expression (Fig. 1E). Relatively comparable
levels of expression were found for an established sur-
face marker, the Na-K-ATPase (Fig. 1F), demon-
strating that the different expression levels of dystro-
phin and its associated glycoproteins in normal vs. mdx
preparations are not an artifact of the subcellular frac-
tionation procedure, differential proteolytic degrada-
tion, protein solubilization, electrophoretic separation,
and/or the immunoblotting methodology.
Expression of Ca2 regulatory proteins in mdx mem-
branes. Immunoblotting with established antibodies to
the principal 1S-subunit of the dihydropyridine recep-
tor and its auxiliary 2- and -subunits revealed no
drastic difference in their expression between normal
and mdx microsomes (Fig. 1, G–I). The RyR1 isoform of
the SR Ca2 release channel and the fast SERCA1
isoform of the Ca2-ATPase were also found to exist at
comparable levels in control and dystrophin-deficient
membrane preparations (Fig. 1, J and K). Thus in
contrast to the dramatic reduction in dystrophin-asso-
ciated glycoproteins in mdx membranes (Fig. 1, B–D),
the relative abundance of the two central elements of
excitation-contraction coupling and the central ion
pump responsible for muscle relaxation is not affected
by dystrophic changes. The same was shown for the
major Ca2 binding protein of the terminal cisternae
region, calsequestrin of apparent 63 kDa (Fig. 1L).
Reduced expression of CLPs in mdx membranes. In
stark contrast to calsequestrin, three CLPs recognized
by MAb VIIID12, exhibited a greatly reduced expres-
sion in mdx preparations (Fig. 1L). These luminal SR
Fig. 2. Expression of CLPs in dystrophic mdx skeletal muscle. A:
densitometric scans of representative immunoblots of normal control
and dystrophic mdx membranes labeled with monoclonal antibody
(MAb) VIIID12 to CSQ and CLP demonstrating the greatly decreased
expression of CLP-150, CLP-170, and CLP-220 in dystrophin-defi-
cient microsomes. The relative position of molecular mass standards
(in kDa) is indicated on top of the scans. B: statistical analysis using
paired t-tests documents the significantly reduced relative density of
all 3 CLPs in mdx muscle preparations (n  5; **P 	 0.01; ***P 	
0.001), whereas the expression of CSQ is comparable between nor-
mal and dystrophic membranes. Bars 1 and 2 represent microsomal
membranes isolated from normal control and dystrophic mdx skele-
tal muscle, respectively. Error bars, SD.
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proteins of 
150 kDa (CLP-150), 170 kDa (CLP-170),
and 220 kDa (CLP-220) appear to be the only major
excitation-contraction coupling proteins with different
relative densities in dystrophic microsomes. Immuno-
blotting with antibodies to other minor Ca2 regula-
tory proteins, such as junctin, calmodulin, sarcalume-
nin, 12-kDa FK506 binding protein, slow calsequestrin,
triadin, the sarcolemmal Ca2-ATPase, the Na/Ca2
exchanger, and the -dihydropyridine receptor, did not
result in good enough immunodecoration for proper
evaluation (not shown) and thus could not be studied
further. As illustrated in the densitometric scans of
representative immunoblots of CLPs (Fig. 2A) and the
graphical representation of the relative abundance of
CLP-150, CLP-170, and CLP-220 (Fig. 2B), the three
CLPs are much less abundant in mdx membranes
compared with normal control microsomes.
Diagonal two-dimensional immunoblot analysis of
CLPs. To further investigate the status of CLPs in
dystrophic microsomes, two different two-dimensional
immunoblotting techniques were employed. First, di-
agonal nonreducing/reducing two-dimensional gel elec-
trophoresis (Fig. 3, A and B) and, second, isoelectric
focusing in the first dimension and standard SDS poly-
carylamide gel electrophoresis in the second dimension
(Fig. 3, C and D). Diagonal two-dimensional gel elec-
trophoresis was used to differentiate between calse-
questrin of 63 kDa and its oligomeric structures on the
one hand and the three CLPs of 150 kDa, 170 kDa, and
220 kDa on the other hand. Proteins remaining on the
diagonal represent monomers. Immunodecorated spe-
cies exhibiting distinct shifts to the left represent oli-
gomeric forms of the protein situated on the diagonal
line. Figure 3, A and B, clearly demonstrates that a
subpopulation of the 63-kDa calsequestrin species ex-
ists in both normal control and dystrophic mdx mem-
branes as high-molecular-mass clusters of 600 kDa.
The protein spot representing calsequestrin monomers
in two-dimensional gels is relatively broad (Fig. 3, A
and B). This effect is most likely due to the uniform
Fig. 3. Two-dimensional immunoblot analysis of CLPs
in dystrophic mdx skeletal muscle. Shown are repre-
sentative immunoblots using diagonal nonreducing/re-
ducing 2-dimensional gel electrophoresis (NR/RED) for
the determination of complex formation (A and B) and
standard 2-dimensional gels using isoelectric focusing
(pH 3–10) in the first dimension and reducing SDS
polycarylamide gel electrophoresis in the second di-
mension (IEF/RED) for the evaluation of isoelectric
point values of individual protein isoforms (C and D). A
and C: normal control microsomes; B and D: mem-
branes isolated from dystrophic mdx muscle. Positions
of immunodecorated protein bands are marked by ar-
rowheads. Sizes of molecular mass standards (in kDa),
as deduced from rat myofibrillar proteins, are indicated
on the left and on the top of the blots.
Fig. 4. Immunoprecipitation analysis of CLPs in dys-
trophic mdx skeletal muscle. Shown are immunoblots
of solubilized membrane fractions immunoprecipitated
(IP) with MAb VIIID12 to CSQ of apparent 63 kDa and
CLP-150, CLP-170, and CLP-220, which were subse-
quently immunolabeled with the same antibody to CSQ
(A) or a polyclonal antibody to junctin (JN; B). Lanes 1
and 2 represent microsomal membranes isolated from
normal control and dystrophic mdx skeletal muscle,
respectively. Positions of immunodecorated protein
bands are marked by arrowheads. Sizes of molecular
mass standards (in kDa), as deduced from rat myofi-
brillar proteins, are indicated on the left.
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tube gel system used in the nonreducing first dimen-
sion, which generally does not concentrate protein
samples as well as slab gels. In contrast to calseques-
trin, CLP-150, CLP-170, and CLP-220 remain on the
diagonal after nonreducing/reducing two-dimensional
gel electrophoresis and do not appear to exist under
nonreducing conditions as higher molecular mass
structures. In analogy to the findings using one-dimen-
sional immunoblotting, this two-dimensional tech-
nique confirms the greatly reduced expression of the
three CLPs in dystrophic membranes (Fig. 3, A and B).
Two-dimensional isoelectric focusing analysis of
CLPs. To determine potential changes in the isoform
expression pattern of calsequestrin or CLPs with re-
spect to pI values, immunoblotting of standard two-
dimensional gels with isoelectric focusing in the first
dimension and reducing SDS polycarylamide gel elec-
trophoresis in the second dimension was performed. As
shown by one-dimensional immunoblotting and the
above-described diagonal two-dimensional method,
this gel system also demonstrated a drastic reduction
in the expression levels of the three CLPs of
150 kDa,
170 kDa, and 220 kDa (Fig. 3, C and D). In both normal
control and dystrophic membranes, the main calse-
questrin species of apparent 63 kDa migrated at a pI
value around 5. In contrast to mdx preparations, nor-
mal microsomes also showed calsequestrin species at
approximately pH 7–9. The calsequestrin species of
Fig. 5. Analysis of the Ca2 binding capacity and Ca2-
ATPase activity of the sarcoplasmic reticulum from
dystrophic mdx skeletal muscle. A: graphical represen-
tation of the Ca2 binding properties of normal control
and dystrophic mdx microsomes (n  5; **P 	 0.01;
unpaired t-test). Ca2 binding was determined using
equilibrium dialysis, whereby normal mouse muscle
microsomes bound 
170 nmol Ca2/mg protein. For
comparison, B graphically represents the Ca2-ATPase
enzyme activity of normal control and dystrophic mdx
microsomes (n  8). With the use of a paired t-test, no
statistically significant difference was found, whereby
normal mouse muscle microsomes exhibited an enzyme
activity of 
2 mol Pi mg protein1 min1. Error bars,
SD.
Fig. 6. Immunofluoresence localization of CSQ in dys-
trophic mdx skeletal muscle. Shown are transverse
cryosections of normal control (A, C, E) and dystrophic
mdx (B, D, F) skeletal muscle fibres, histologically
stained with hematoxylin and eosin (H&E; A and B)
and immunolabeled with antibodies to the Dp427 iso-
form of dystrophin (C and D) and CSQ (E and F). Many
dystrophic fibers exhibited central nucleation (B) and a
complete absence of dystrophin (D), establishing the
mutant status of the mdx muscle used in this study.
The different staining intensities of individual muscle
cells for CSQ reflect the varying contents of this Ca2
binding protein in fast-twitching vs. slower fibers (E
and F), whereby no apparent difference was observed
between normal and dystrophic tissues. Bar  20 m.
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differing pI value probably represent differently phos-
phorylated protein species. This agrees with the idea
that native calsequestrin exists as a mixture of non-
phosphorylated and phosphorylated Ca2 binding com-
plexes. In microsomes from normal skeletal muscle,
the major species of the three different CLPs exhibited
an electrophoretic mobility at a pI value of 
7–8. This
is especially well illustrated for CLP-220 in Fig. 3C.
Immunoprecipitation analysis of CLPs. To confirm
the findings from the one- and two-dimensional immu-
noblotting, immunoprecipitation experiments using
MAb VIIID12 were performed (Fig. 4). This antibody
not only recognizes both calsequestrin and CLPs in
immunoblotting, but also precipitates these proteins as
shown in Fig. 4A. Although the immunoprecipitation
technique is not a reliable quantitative method due to
potential variations in the interactions between anti-
bodies and antigens in different starting materials, it
can be employed in a semiquantitative approach. The
immunoprecipitated fractions from normal control and
mdx samples exhibited approximately equal amounts
of the 63-kDa calsequestrin species (Fig. 4A) and the
calsequestrin-binding protein named junctin (Fig. 4B).
On the other hand, the CLPs were found at a lower
relative concentration in the dystrophic fraction, which
was especially well demonstrated for CLP-220 (Fig.
4A). It has been recently established that a subpopu-
lation of calsequestrin exists in a heterogeneous triad
complex closely associated with junctin, triadin, and
the RyR Ca2 release channel (29). The close neighbor-
hood relationship between calsequestrin and junctin
has been confirmed by our immunoprecipitation anal-
ysis, and this interaction does not appear to be changed
in the dystrophic phenotype. Immunolabeling with an-
tibodies to the RyR1 isoform of the Ca2 release chan-
nel and the junctional marker triadin did not reveal
the presence of these components in mouse muscle
complexes immunoprecipitated by MAb VIIID12. Pos-
sibly these large triadic membrane complexes disinte-
grate during the subcellular fractionation and electro-
phoretic separation procedure, and/or the relative
abundance of triadin and the RyR is too low to be
detected by immunoblotting.
Reduced Ca2 binding of dystrophic SR. As shown in
Fig. 5A, Ca2 binding assays of SR vesicles showed
that Ca2 binding was significantly reduced in mdx
preparations compared with normal control mem-
branes. With the use of equilibrium dialysis, an 
20%
decrease in the overall capacity to sequester calcium
ions was demonstrated in dystrophin-deficient micro-
somal membranes. This pathophysiological finding of
disturbed luminal Ca2 homeostasis agrees with the
results from our immunoblot analysis of CLPs. Possi-
bly the reduction in the Ca2 binding proteins CLP-
150, CLP-170, and CLP-220 causes a decreased capac-
ity of the dystrophic SR to function as a Ca2 reservoir.
For comparison, no statistically significant difference
in the Ca2-ATPase enzyme activity was determined
(Fig. 5B). Thus, although earlier studies have shown
impaired maximum velocity of Ca2 uptake (36), the
total Ca2-ATPase activity does not seem to be im-
paired in dystrophic skeletal muscle fibers.
Immunofluorescence localization of calsequestrin in
dystrophic muscle. Because immunoblotting and im-
munoprecipitation studies revealed a reduced expres-
sion of CLPs in mdx membranes, immunofluorescence
microscopy was used to establish whether labeling
with MAb VIIID12 detects any potential changes in the
localization and/or abundance of the antigens recog-
nized by this probe. Comparative histological staining
with hematoxylin and eosin of normal and mdx muscle
fibers clearly demonstrated the dystrophic phenotype
of the mouse mutant (Fig. 6, A and B). While trans-
verse cryosections of normal muscle fibers showed pe-
ripheral nucleation exclusively, large numbers of mdx
muscle cells clearly exhibited central nucleation, thus
demonstrating abnormal degeneration-regeneration
cycles in theses fibers. Immunofluorescence microscopy
with an antibody to the Dp427 isoform of dystrophin
showed staining of the cellular periphery in normal
muscle and a complete absence of this membrane cy-
toskeletal protein in mdx fibers (Fig. 6, C and D), thus
establishing the mutant status of the animal model
employed in this study. Immunolabeling with antibody
VIIID12 to calsequestrin and the CLPs did not reveal a
drastic difference in the localization pattern or the
relative intensity of the immunofluorescence signal
(Fig. 6, E and F). Probably, this technique does not
reflect minor changes in the abundance and/or recog-
nizes the calsequestrin isoform of 63 kDa better than
the CLPs, CLP-150, CLP-170, and CLP-220. However,
fiber-type-specific differences in the distribution of
calsequestrin were recognized by this antibody, stain-
ing fast-twitching fibers more intensely than slower
fibers (Fig. 6, E and F). No difference in the distribu-
tion of fast and slow fibers was detected by this method
between normal control and dystrophic mdx prepara-
tions.
DISCUSSION
Despite the fact that primary genetic defects have
been identified for Duchenne muscular dystrophy and
related muscular disorders (1) and an enormous
amount of clinical data has been gathered about mus-
cle weakness in these inherited diseases (17), the mo-
lecular processes leading to muscle cell destruction
have not been adequately revealed. Deficiency in the
membrane cytoskeletal protein dystrophin has been
shown to be the underlying genetic cause for muscle
weakness (38). In normal muscle, dystrophin is pro-
posed to act as a molecular anchor that mediates a
transsarcolemmal linkage between the extracellular
matrix component laminin and the actin membrane
cytoskeleton (6, 59). In dystrophic fibers, the absence of
dystrophin causes the disintegration of a surface mem-
brane complex consisting of a variety of sarcolemmal-
associated proteins named dystroglycans, sarcogly-
cans, sarcospan, dystrobrevins, and syntrophins (14).
It is not clear how reduced expression levels of these
dystrophin-associated proteins trigger secondary ab-
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normalities in muscular dystrophy. However, in an
effort to develop treatments for inherited neuromuscu-
lar disorders, a better understanding of these second-
ary molecular and cellular mechanisms that lead to
contractile failure is essential.
The secondary molecular mechanisms underlying
skeletal muscle fiber necrosis are the link between a
specific mutation in the human Duchennne muscular
dystrophy gene on the one hand and end-stage myone-
crosis on the other hand. Thus it is essential to analyze
the pathobiochemical processes that impair normal
muscle function in an effort to understand the overall
molecular pathogenesis of muscular dystrophy. In this
study, we have determined potential changes in the
expression pattern of Ca2 regulatory components in-
volved in excitation-contraction coupling, because vari-
ations in ion homeostasis might trigger directly proteo-
lytic degradation and/or compensatory changes in
protein expression within cells (10, 70). This report
clearly shows that the three CLPs, termed CLP-150,
CLP-170, and CLP-220, are greatly reduced in their
expression in microsomal vesicles isolated from dystro-
phin-deficient skeletal muscle homogenates. The find-
ing that the overall Ca2 binding capacity of SR vesi-
cles derived from mdx muscle fibers is reduced by 20%
agrees with this result.
On the other hand, the impaired luminal Ca2 buff-
ering might not be exclusively based on changes in the
expression of CLPs. First, under normal resting condi-
tions, probably not all ion-binding sites are occupied in
the luminal Ca2 reservoir complex of the terminal
cisternae region (5). Second, calsequestrin of apparent
63 kDa is a much more abundant Ca2 binding protein
compared with all other Ca2 buffering elements in the
SR, including the CLPs (45). It is, therefore, possible
that even small changes in the 63-kDa calsequestrin
isoform might account, at least partially, for the ob-
served decrease in the overall Ca2 binding capacity of
the SR from dystrophic mdx skeletal muscle fibers. On
the other hand, if a very large fraction of calsequestrin
binding sites is not occupied in muscle fibers at rest,
then a moderate reduction in Ca2 binding might be
without any functional significance. However, it is un-
likely that a reduction in one-fifth of the buffering
capacity does not influence overall Ca2 cycling pat-
terns.
Both the pathobiochemical status of the CLPs and
the pathophysiological status of the luminal Ca2 res-
ervoir complex suggest that dystrophic skeletal muscle
fibers exhibit abnormal ion homeostasis. The idea that
changes in Ca2 handling play an important role in the
degeneration process of dystrophin-deficient fibers is
confirmed by the analysis of myotubes from transgenic
mdx mice expressing dystrophin (16). Whereas dystro-
phic fibers show higher resting levels of subsarcolem-
mal free calcium ions (48), which in turn appears to
Fig. 7. Diagrammatic representation of the possible involvement of CLPs in the molecular pathogenesis of
muscular dystrophy. Based on the analysis of Ca2 regulatory membrane proteins in dystrophin-deficient mdx
muscle preparations presented in this report, the model diagrams comparatively illustrate apparent differences in
Ca2 handling in normal (A) and dystrophic (B) skeletal muscle fibers. A major difference between normal and
dystrophic fibers appears to be a drastic reduction in CLPs in the lumen of the sarcoplasmic reticulum (SR). The
primary deficiency in the dystrophin isoform Dp427 triggers a reduction in sarcolemmal (SL) dystrophin-associated
proteins (DAPs), which in turn may impair the linkage between the subsarcolemmal actin cytoskeleton (AMC) and
the extracellular matrix (ECM) component LAM. Although no massive change in the overall cytosolic Ca2 levels
([Ca2]C) in dystrophic muscle fibers has been confirmed, influx of calcium ions trigger an increase in subsar-
colemmal ion levels ([Ca2]SS), causing increased Ca2-dependent proteolysis. Variations in the subsarcolemmal
Ca2 level is accompanied by a distinct reduction in CLPs. This then could result in impaired Ca2 sequestration
within the lumen ([Ca2]L) of the SR, thereby contributing to the molecular pathogenesis of muscular dystrophy.
In addition, impared functioning of the SERCA and/or an increased turnover of the fast-twitch Ca2 binding
protein parvalbumin (PV) might be involved in abnormal ion handling. Other key components of Ca2 homeostasis
and excitation-contraction coupling are also indicated in the diagram: the transverse-tubular (TT) DHPR, the RyR
Ca2 release channel, sarcalumenin (SAR), triadin (TRI), and calreticulin (CAL).
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increase Ca2-dependent proteolysis (3), restoration of
dystrophin results in normal resting Ca2 levels and
Ca2 leak channel activity (16). Hence the stabilization
of the sarcolemmal membrane cytoskeleton via resto-
ration of dystrophin in transgenic mdx mice strongly
indicates that abnormal intracellular Ca2 levels par-
ticipate in the pathophysiological mechanisms of mus-
cular dystrophy (2). In agreement with this hypothesis,
we show here that a possible central factor in the
abnormal ion homeostasis of dystrophic cells is abnor-
mal Ca2 binding in the lumen of the SR.
In addition to the reduced expression of Ca2 bind-
ing proteins of the terminal cisternae region in dystro-
phin-deficient skeletal muscle fibers, previous studies
on dystrophic muscle have shown that the SR Ca2-
ATPase, calsequestrin, the dihydropyridine receptor,
and the cytoplasmic Ca2 binding protein parvalbumin
might be affected in the disease process (27, 36, 56, 61).
The analysis of muscle specimens from patients af-
flicted with Duchenne muscular dystrophy using the
cationic carbocyanine dye Stains-All indicated a re-
duced expression of the 63-kDa calsequestrin band
(56). Our immunoblot analysis with the highly specific
MAb VIIID12 to calsequestrin did not confirm this
finding with respect to mdx muscle preparations. The
previous finding that mRNA levels of the dihydropyri-
dine receptor are affected in mdx muscle fibers (61)
does not seem to be reflected on the protein level.
Immunoblotting with antibodies to the 1S-subunit,
2-subunit, and -subunit of this transverse-tubular
receptor did not reveal any drastic changes in its ex-
pression profile in dystrophic microsomes. In addition
to reduced Ca2 binding in dystrophic muscle pre-
sented here, the SERCA Ca2-ATPase isoform was
shown to be functionally altered in muscular dystrophy
(36). Although we can show here that neither the
relative abundance nor the total enzyme activity of this
pump protein is altered, the previous biochemical anal-
ysis suggests that the maximum velocity of Ca2 up-
take is impaired in dystrophic mdx fibers (36). In ad-
dition, findings on the major cytoplasmic Ca2 binding
element parvalbumin in dystrophic fast-twitch fibers
(27) suggest that overall Ca2 handling is reorganized
in mdx muscle. The fact that parvalbumin protein
expression is not changed in muscular dystrophy (34),
but an upregulation of parvalbumin mRNA levels is
observed (27), implies increased turnover rates for this
protein. Thus changes in both luminal and cytosolic
Ca2 buffering and Ca2 uptake into the SR might
contribute to pathophysiological Ca2 cycling in dys-
trophin-deficient fibers. Additional unknown factors
are the dystrophic status of the sarcolemmal calmodu-
lin-dependent Ca2-ATPase and the surface Na/Ca2
exchanger. Potential abnormalities in these Ca2 han-
dling components might also play a role in altered ion
homeostasis in mdx muscle fibers.
In conclusion, as diagrammatically shown in Fig. 7,
the reduction in CLPs represents a major difference
between normal and dystrophic skeletal muscle fibers.
The deficiency in the dystrophin isoform Dp427 leads
primarily to a reduction in dystrophin-associated pro-
teins, such as the sarcoglycans, dystroglycans and sar-
cospan. This in turn may directly trigger destruction of
the plasmalemmal integrity by weakening the link
between the subsarcolemmal actin cytoskeleton and
the extracellular matrix component laminin. Influx of
calcium ions causees an increase in intracellular levels,
and that could be an important factor in the Ca2-
induced myonecrosis. As demonstrated in this study,
these changes in the subsarcolemmal Ca2 level are
accompanied by a distinct reduction in Ca2 binding
proteins. The pathophysiological consequence of this
variation in protein expression is impaired Ca2 se-
questration within the lumen of the SR. Hence, the
lack of the dystrophin-glycoprotein complex may trig-
ger disturbed surface Ca2 fluxes, which then influence
downstream Ca2 handling, thereby resulting in dis-
tinct changes in the expression profile of a subset of key
Ca2 handling proteins. This might explain one of the
important steps in the molecular pathogenesis of mus-
cular dystrophy.
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